By Jane Metlikovec, Georgie Pilcher and Grant McArthur
May 23, 2007
AUSTRALIAN women will be the first to use a cervical vaccine for older women as a controversy erupted yesterday over anti-cancer jab Gardasil.
The Therapeutic Goods Administration this week approved the Cervarix vaccine in women aged from 10 up to 45.
Cervarix is the first of its kind for women over 26 and may be available in months, according to maker GlaxoSmithKline
Gardasil can only be used in younger women.
Cervarix's approval came as it was revealed dozens of schoolgirls fell ill after receiving their Gardasil shots on May 7.